EKF Diagnostics Holdings plc

    Jurisdiction
    United Kingdom
    LEI
    213800DXTF3EAUK1AR05
    ISIN
    GB0031509804 (EKF.L)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €0.32 3.6% overvalued
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. Read full profile

    Fundamentals

    Net revenue
    €117.96M
    Gross margin
    47.5%
    EBIT
    €12.71M
    EBIT margin
    10.8%
    Net income
    €9.86M
    Net margin
    8.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €60.39M -48.8% €6.51M -34.0%
    €65.75M +8.9% €7.95M +22.2%
    €70.68M +7.5% €9.06M +14.0%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    £1.20
    Ex date
    Payment date
    Dividend payout ratio
    63.4%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Earnings Calls

    Latest earnings call: September 16, 2025 (Q2 2025)

    Add to watchlist

    Notifications